cannabis market research
Linkedin

• United Kingdom · free market report · September 2026

All the intelligence you need to enter the UK medical cannabis market, and to make the most of it once you’re in.

Our 34-page report follows what patients actually received — volume, value, potency, price and who supplied it — read line by line from the NHSBSA’s own dispensing records. It’s free.

England only
The NHSBSA record covers England alone and is under-reported, so it undershoots the UK market, probably by a wide margin. Read every figure here as a floor. How we handle it →
Get the free report →
See what's inside ↓
Counted, not estimated
1.77m
items of medical cannabis dispensed in England in 2025, six times the 2023 volume
44k2021
124k2022
283k2023
669k2024
1.77m2025
Items dispensed by year · NHSBSA, England onlyA floor, not the UK total
1.77m
items dispensed in England, 2025
£157m
at August 2026 list prices
+165%
items, 2025 on 2024
30 t
flower imported into the UK, 2025
1,009
SKUs dispensed in the year

Imports cover the whole UK. Everything else is England only — read it as a floor.

• The problem

A patient estimate can’t tell you what was dispensed. The dispensing record can.

You can find guesses at how many people in the UK take medical cannabis. What you won’t find in them is what those patients received, at what strength and price, or who supplied it. The report reads the answer from 394,090 NHSBSA dispensing records, resolves every line to a product, and says plainly that the record covers England only and undercounts the UK market.

1
Counted from the record, line by line
Two freedom-of-information releases, January 2019 to February 2026, combined into one series that reconciles exactly to the NHSBSA’s annual totals.
2
Resolved to the product
Free-text names matched to a 1,192-SKU index carrying format, strength, origin, grower and dated list price.
3
Tested before it is published
Every cut is re-run on a hold-out. Importer and distributor history failed that test, so the report leaves it out.
Read as a floor
England only, and it undershoots the UK market.
20–25%
a conservative uplift to reach a total-UK view
~£200m
the 2025 UK market at list prices, on that view
The NHSBSA release covers prescriptions dispensed in England. Wales, Scotland, Northern Ireland and the Crown Dependencies are outside it, and pharmacies submit it by hand, so some dispensing never reaches it. Levels are floors; shares and trends need no adjustment.

• Free — what your email unlocks

The full 34-page report, with every value labelled and every source named.

One form, and the PDF comes straight to your inbox. Eight chapters, in the order you would size up any market.

01 · Free
The market and who reaches it
Chapters 00–02 · pages 4–13
✓Imports doubled to 30 tonnes, and Canada now ships most of them direct
✓Items and value every quarter since 2021, and the total-UK view
✓The monthly clinic leaderboard, September 2025 to August 2026
02 · Free
The shelf and who supplies it
Chapters 03–04 · pages 14–20
✓Thirteen routes from grower to pharmacy, mapped owner by owner
✓Launches, carry-overs and delistings, reconciled to the unit
✓Operator shares every year since 2021, and flower grower by grower
03 · Free
Price, potency and formats
Chapters 05–07 · pages 21–33
✓Like-for-like list-price cuts by price tier and THC band
✓Kilograms dispensed by THC band, quarter by quarter
✓Live resin and rosin, from nothing to a third of cartridges
Get the free report →

• What the report shows

The market doubled every year, and no single company holds it any more.

Five numbers the report opens with, all read from England’s dispensing record, which undercounts the UK market. Below them, extracts from each chapter.

+165%
items dispensed, 2025 on 2024
548 → 1,009
SKUs dispensed in the year
−36 pts
largest operator’s share since 2023
+615%
vape cartridges in a year
−5.5%
average listed flower price, Oct 2025 → Aug 2026
Size and growth · chapter 01, pages 7–10

Items have more than doubled every year since 2021.

Quarterly growth has not dropped below 13% since 2022 and averaged 25% a quarter. Six times the 2023 volume: 1.77 million items in 2025 against 283,000 in 2023.

Items dispensed in England, by year
0500k1m1.5m2m44k2021124k2022283k2023669k20241.77m2025

Items rose 165% in 2025, after +183%, +128% and +136% in the three years before. The fourth quarter alone dispensed 617,284 items.

NHSBSA FOI_03941 and FOI-03965 · England only · report p.7

Value dispensed in England, £m at list prices
£0m£50m£100m£150m£200m£6.6m2021£15m2022£31m2023£69m2024£157m2025

Value reached £157m in 2025 but rose slower than items: the average item fell from £194 to £84 as 10 g packs and single vape cartridges took over.

Items × August 2026 list prices, constant across years · NHSBSA, England only · report p.8

Who supplies it · chapters 00 and 04, pages 4–6 and 19–20

Curaleaf went from 61% of items to 25%, and it is still growing.

Montu, 4C Labs, Aurora and Releaf joined Curaleaf in a five-way top tier, the active-supplier count nearly quintupled, and Curaleaf’s own items rose from 281k to 452k in 2025.

Share of items, % — Curaleaf and the five largest operators
0%25%50%75%100%60%25%20212022202320242025CuraleafFive largest operators

Curaleaf fell from 61% to 25% while its own items rose 2.6-fold. The number of operators needed to reach 80% of items went from 5 to 17.

Operator groups consolidate brands under their owner · NHSBSA, England only · report p.19

Flower imported against flower dispensed, tonnes
0102030402.00.720218.61.920226.94.0202315.08.8202430.120.32025Imported into the UKDispensed in England

Imports doubled to 30.1 tonnes in 2025 against 20.3 t dispensed in England, and Canada shipped 57% of them, up from 17%. The gap is UK extraction, the other nations and stock for a market still doubling.

Home Office import FOIs (UK, by exporting country) against NHSBSA dispensing (England only) · report p.5

Flower dispensed in 2025, by country of cultivation
Canada49.0%Portugal23.7%United Kingdom6.8%South Africa3.5%North Macedonia2.2%Spain1.7%

Canada grows half of UK flower on 78 farms, and no single Canadian farm holds even a tenth of it. The largest grower overall holds 21.5%.

Grower = cultivating licence holder; 3% of 2025 flower has no resolved grower · NHSBSA, England only · report p.20

13 routes from grower to pharmacy, September 2026
Hover or tap a route. The percentage is its share of 2025 items where the dispensing record can attribute one; the full map in the report carries every grower, importer, brand, clinic and pharmacy.
Vertically integratedClinic-ledImport or manufacturing platformBrand owner or distributorIntegrating 2025–26
Curaleaf25.5%CuraleafVertically integratedGrowersTerra Verde (PT), Northern Green (CA), Medalchemy (ES)Clinic · pharmacyCuraleaf Clinic · Curaleaf Pharmacy2025 items25.5% of all items dispensedAurora bid, Aug 2026Lyphe · TilrayLyphe · TilrayVertically integratedGrowersTilray Cantanhede (PT), GroVida (PT), ECS Botanics (AU)Clinic · pharmacyLyphe Clinic · Lyphe DispensaryTilray bought Lyphe, Apr 2026WellfordWellfordVertically integratedGrowersAqualitas (CA) and partner growersClinic · pharmacyWellford Clinics · NewgroveMontu12.2%MontuClinic-ledGrowersLittle Green Pharma (DK), ABcann (CA), other Canadian LPsClinic · pharmacyAlternaleaf · Montu Pharmacy2025 items12.2% of all items dispensedReleaf4.9%ReleafClinic-ledGrowersGlass Pharms (UK), Somaí (PT)Clinic · pharmacyReleaf · Releaf Dispensary2025 items4.9% of all items dispensedMamedicaMamedicaClinic-ledGrowersCheers · Medz (CA), Miracle Valley (CA), Somaí, Glass PharmsClinic · pharmacyMamedica · Mamedica DispensaryAurora6.4%AuroraIntegrating 2025–26GrowersAurora Canada, Safari Flower (CA), Aurora Nordic (DK)Clinic · pharmacyHAP Pharma (bought Aug 2026)2025 items6.4% of all items dispensedBought Internode and HAP Pharma, Aug 2026IPS PharmaIPS PharmaImport or manufacturing platformGrowersPharmaCann (MK), Aurora · Tilray, Northern Leaf (JE)Clinic · pharmacyIntegro · IPS PharmacyGrowGrowBrand owner or distributorGrowersPharmaCann (MK), SafriCanna (ZA), HollyMood (TH)Clinic · pharmacyAuravia · Grow pharmacyBought Avida, Jul 2025; now in a CVACantourageCantourageImport or manufacturing platformGrowersLot420 · Green Karat (CA), Portocanna (PT) and othersClinic · pharmacyCantourage Clinic · CedarwoodHilltop LeafHilltop LeafImport or manufacturing platformGrowersLittle Green Pharma (DK), Aurora resin carts (CA), ECS (AU)Clinic · pharmacyOpen market4C Labs · Xeal10.9%4C Labs · XealBrand owner or distributorGrowersOrganigram, AgMedica, Rubicon (1964), MG Health (CA)Clinic · pharmacySupplies Mamedica · Xeal Dispensary2025 items10.9% of all items dispensedHologramHologramImport or manufacturing platformGrowersSomaí (PT), Thai flower (TH)Clinic · pharmacyOpen marketOwnership event, Sep 2026
Patients and access · chapter 02, pages 11–13

Alternaleaf passed Releaf in May 2026, and the clinic leaderboard is still moving.

Clinic traffic leads the dispensing record rather than mirrors it. Prescribing has broadened, but 19 clinicians wrote half of all items in 2025 and fewer than 1% of eligible specialists prescribe at all.

Share of tracked UK clinic web traffic, %
0%20%40%60%27%21%20%Sep 25Feb 26May 26Aug 26ReleafAlternaleafCuraleaf Clinic

Releaf gave up 29.3 points in eleven months and Alternaleaf, Montu’s UK clinic, took 14.7 of them. It has led since May 2026.

SimilarWeb estimates compiled monthly; Oct–Nov 2025 not captured · report p.13

Prescribers writing at least one dispensed item
01002003001720193720209820211162022164202320620242532025

From 17 clinicians in 2019 to 253. The five largest wrote 81% of items in 2019 and 24% in 2025.

Prescriber of record on the dispensed item, pseudonymised · NHSBSA FOI-03965, England only · report p.11

The product · chapters 03, 06 and 07, pages 14–18 and 25–33

The product moved faster than the price.

Stronger flower, smaller packs and a vape category that barely existed in 2024. More than half of 2025’s shelf did not exist a year earlier.

7.1×
vape cartridges dispensed, 2025 on 2024
33%
of cartridges live resin or rosin, from zero
16% → 58%
of flower volume in 10 g packs, 2022 to 2025
545
SKUs dispensed for the first time in 2025
Volume-weighted THC of dispensed flower, %
0.0%10.0%20.0%30.0%24.9%22 Q123 Q124 Q125 Q4Average THC

From 18.4% in 2022 to 24.9% at the end of 2025, rising every single quarter. 29% of volume is now 28% THC or stronger.

Declared THC on the prescription, falling back to the product index · NHSBSA, England only · report p.26

Share of items held by the ten biggest SKUs
0%20%40%60%80%66%202159%202251%202325%202417%2025

In 2021 ten products were most of the market. In 2025 the biggest single SKU held under 3%, and 117 brands were dispensed.

SKUs ranked inside each year · NHSBSA, England only · report p.17

Price · chapter 05, pages 21–24

Prices are easing slowly, and the cuts are landing on premium flower.

75 of 400 flower SKUs listed at both dates were cut. The gram patients actually chose cost £6.59 at the end of 2025, against a £6.70 shelf average.

Like-for-like list-price change by THC band, Oct 2025 → Aug 2026
Under 20% THC−0.1%20–24%−2.1%24–28%−4.9%28% and over−7.7%0%

Across 400 flower SKUs priced at both dates, lists fell 3.5%. The cuts landed at the top: −7.7% at 28% THC and over, almost nothing under 20%.

Same SKUs at two formulary dates, isolating price changes · report p.22

Price per milligram of THC, 2025, by origin
South Africa2.50pCanada2.61pNorth Macedonia2.67pPortugal2.95pSpain3.73pUnited Kingdom3.87p

Canadian flower costs more per gram than Portuguese — £6.85 against £6.10 — but at 26.3% THC it is cheaper per milligram. UK-grown is the dearest THC on the shelf.

Weighted price per gram ÷ (weighted THC% × 10 mg) · August 2026 list prices · England · report p.23

Free report
Every chart above is an extract. The report carries the full series, chapter by chapter, with every value labelled and every source named.
Get the free report →

• Look inside

Eight chapters, and the question each one answers for you.

Pick a chapter to see what is in it and the number it opens with.

Chapter 00 · pages 4–6
2026 now
What does the market look like this year, before the dispensing record catches up?
  • ✓The formulary doubled in a year — and only half of it is in stock
  • ✓Imports doubled to 30 tonnes, and Canada now ships most of them direct
  • ✓Thirteen routes from grower to pharmacy, mapped owner by owner
818
products on the formulary, from 374 a year earlier
Get the full chapter →
Chapter 01 · pages 7–10
Size and growth
How big is it, how fast is it growing, and in which formats?
  • ✓Items and value by quarter since 2021, with every value labelled
  • ✓Why value grows slower than items — and what the total UK market is worth
  • ✓Peak flower, and the vapes compounding faster than anything else
£157m
dispensed in England in 2025, at list prices
Get the full chapter →
Chapter 02 · pages 11–13
Patients and access
Who prescribes, and which clinics are winning the patient?
  • ✓From 17 prescribers to 253, and why the record counts who signs, not who decides
  • ✓The monthly clinic leaderboard, September 2025 to August 2026
  • ✓Where the 29 share points Releaf gave up actually went
253
active prescribers in 2025, from 17 in 2019
Get the full chapter →
Chapter 03 · pages 14–18
The shelf
How many products are there, how fast do they turn over, and who holds the shelf?
  • ✓SKUs dispensed every quarter, against what is listed
  • ✓Launches, carry-overs and delistings, reconciled to the unit
  • ✓Fragmentation by SKU rank, and brands by format
545
SKUs dispensed for the first time in 2025
Get the full chapter →
Chapter 04 · pages 19–20
Who supplies it
Which operators and growers actually move the volume?
  • ✓Operator shares every year since 2021, with items in each segment
  • ✓Flower by country of cultivation, grower by grower
  • ✓Where flower was grown against where it was shipped from
61% → 25%
Curaleaf’s share of items, 2023 to 2025
Get the full chapter →
Chapter 05 · pages 21–24
Price
What do patients pay, where are prices falling, and what does THC cost?
  • ✓The weighted gram at constant prices, 2022 to 2025
  • ✓Like-for-like list-price cuts by price tier and THC band
  • ✓Pence per milligram of THC and price range, origin by origin
−7.7%
list-price cut at 28% THC and over
Get the full chapter →
Chapter 06 · pages 25–29
Flower
What is in the jar — potency, pack size, cultivar and treatment?
  • ✓Kilograms dispensed by THC band, quarter by quarter
  • ✓The 10 g pack becoming the default
  • ✓Indica–sativa labels and irradiation, and why patients ask
24.9%
weighted flower THC, 2025 Q4, from 18.4%
Get the full chapter →
Chapter 07 · pages 30–33
Other formats
What is happening in vapes, oils and oral solids?
  • ✓Vape strength tiers and the jump to 800 mg/g
  • ✓Live resin and rosin, from nothing to a third of cartridges
  • ✓Oils turning into a THC format, and a one-supplier oral-solid category
33%
of vape cartridges are live resin or rosin
Get the full chapter →

• Free · 34 pages · September 2026

Take the whole UK market with you.

Everything on this page comes from the report, and the report goes much further.

  • ✓The market in nine numbers
    Items, value, prescribers, SKUs, brands and the largest operator
  • ✓Thirteen supply routes, mapped
    Grower, importer, brand, clinic and pharmacy for each
  • ✓The monthly clinic leaderboard
    Five largest clinics, September 2025 to August 2026
  • ✓Price, potency and pack size
    Constant-price series and like-for-like list-price cuts
  • ✓The method, in full
    Coverage, hold-out validation and what was withheld
Free download · PDF
UK Medical Cannabis Market Report, September 2026
Tell us where to send it and the PDF comes straight to your inbox.

If the form does not appear, email info@cannamonitor.com and we will send the report over.

• How we built it

England only and under-reported, so every figure is a floor.

You should know the limits of the data before you rely on it. The report measures the market from the dispensing record itself, tests every cut against a hold-out, and leaves out what fails.

☷
Two FOI releases
394,090 records and 3.13 million items, January 2019 to February 2026, combined by union rather than deduplicated.
◉
Every line resolved
49,614 matched aliases and 4,478 strength-aware decisions join each line to a 1,192-SKU product index.
✓
Validated by hold-out
Each measure is recomputed from a partial snapshot, and item totals reconcile exactly to the NHSBSA’s annual counts.
■
Published or withheld
Cuts that fail the hold-out are left out. Importer and distributor history failed, so there is none.
How complete the record is — NHSBSA, England only
100%
Items, quantity, pack size, date
Reported directly
99.3% of items
SKU identity after standardisation
Everything product-level
99.1% of items
List price per g, ml or piece
Value, price bands, price and potency
100% of flower volume
Declared THC and CBD
Potency bands and weighted averages
92% of 2025 flower
Country of cultivation
Origin and grower views, 2025 only
Withheld
Importer and distributor
Withheld as a time series

• Track record

We called it in 2024. The 2026 data confirmed it.

Anyone can describe a market after it moves. We have published the UK numbers from the dispensing record since 2024, and every call below is dated and still online. Pick one to see what we wrote and what the 2026 data shows.

5calls published in 2024
5confirmed by the 2026 data
1.77mitems in 2025, against the 1 million we called
We wrote · Feb & Oct 2024

The market will double again in 2024, and could pass 1 million items by 2025. Earlier, in February 2024, we put 2023 at around 200,000 items.

Read the original →
↓
What the 2026 data shows

2024 more than doubled to 669k, and 2025 reached 1.77 million, 77% above the million we called. 2023 came in at 283,000.

✓ Confirmed and beaten
05001000150020002002832023100017752025What we forecast (k items)What was dispensed (k items)

NHSBSA, England only · report p.7

We wrote · Oct 2024

Flower over 24% THC went from 3% of prescriptions in 2022 to 22% in 2023. We called it an increasingly potency-focused market.

Read the original →
↓
What the 2026 data shows

Weighted flower THC rose every single quarter, from 18.4% in 2022 to 24.9% at the end of 2025, and 29% of volume is now 28% THC or stronger.

✓ Confirmed
0.0%10.0%20.0%30.0%24.9%22 Q123 Q124 Q125 Q4Average THC of dispensed flower, %

NHSBSA, England only · report p.26

We wrote · Oct 2024

Three-quarters of supply was European, but Canadian products were quickly gaining ground, led by demand for high-THC flower.

Read the original →
↓
What the 2026 data shows

Canada shipped 57% of UK flower imports in 2025, up from 17% a year earlier, as producers bypassed EU processors. Canada now grows half of the flower dispensed.

✓ Confirmed
0%20%40%60%17%202457%2025

Home Office import FOIs, whole UK · report p.5

We wrote · Oct 2024

Vapes, capsules and pastilles held about 1% of prescriptions, with room to grow as prescribers and patients got used to them.

Read the original →
↓
What the 2026 data shows

Vape cartridges grew 7.1 times in 2025, live resin and rosin went from nothing to a third of them, and flower’s share slipped from its 2024 peak.

✓ Confirmed
050k100k150k19.9k2024142k2025

NHSBSA, England only · report p.10

We wrote · Nov 2024

Our 2024 report named Curaleaf the leader in flower, oils and capsules.

Read the original →
↓
What the 2026 data shows

Curaleaf is still the largest operator. Its share fell from 61% to 25% as the market crowded in, but its own items rose 2.6-fold in two years, and it supplies 99% of oral solids.

✓ Confirmed
0k200k400k600k172k2023281k2024452k2025

Items dispensed, NHSBSA, England only · report p.19

The receipts, in the order we published them
Feb 2024Clinics drive exponential growth in the UKRead →Oct 2024High-THC flower leads a market in full bloomRead →Nov 2024UK market report, executive summary (PDF)Read →May 2026The UK market doubles again, and flower loses shareRead →

• Published intelligence on the UK

Everything we have published on the UK, newest first.

The report is the latest piece in a record that goes back to 2024. Each article below is built from the same dispensing data and carries the number it opened with.

Free · 34 pages
1.77m
items dispensed in England in 2025
United Kingdom · Sep 2026
UK Medical Cannabis Market Report 2026
Eight chapters on volume, value, potency, price and supply, every value labelled and every source named
Get it free →
Hash and rosin reach the international medical shelf
United Kingdom · 22 Jul 2026
Hash and rosin reach the international medical shelf
The UK listed its first medical hash in May 2026, and carries 3 in-stock concentrates against 98 in Ontario
Read →
The UK market doubles again, and flower loses share
United Kingdom · 14 May 2026
The UK market doubles again, and flower loses share
Vapes went from 2% to 5% of dispensed items between 2024 and H1 2025, the first crack in a flower monoculture
Read →
Canada ships 276 tonnes in 2025, and the UK is its next unlock
Canada → UK · 8 Apr 2026
Canada ships 276 tonnes in 2025, and the UK is its next unlock
C$40m of Canadian flower went to the UK in 2025, up 267%, the fastest growth of any established corridor
Read →
High-THC flower leads a market in full bloom
United Kingdom · 7 Oct 2024
High-THC flower leads a market in full bloom
Flower over 24% THC went from 3% to 22% of flower prescriptions in a single year
Read →
Clinics drive exponential growth in the UK market
United Kingdom · 16 Feb 2024
Clinics drive exponential growth in the UK market
Items nearly tripled in 2022 as private clinics took over patient onboarding
Read →
See all insights →

• Free report or Decide

The report is dated September 2026. Decide keeps moving.

Every number in the report is a live dataset in Decide, updated as each FOI release, formulary snapshot and clinic month lands.

What you get
Free report
🔒 Included in Decide (paid)
Market size and growth
✓2021 to 2025, as published in September 2026
✓Refreshed with each NHSBSA release
Products on the shelf
✓Shelf structure, launches and the biggest SKUs
✓Every SKU by format, operator, strength and quarter
Prices
✓Two formulary dates, compared like for like
✓Every formulary snapshot, dated
Clinics
✓The five largest, September 2025 to August 2026
✓Every tracked UK clinic, month by month
Supply chain
✓Thirteen routes from grower to pharmacy
✓Grower, importer and distributor per SKU, with ownership events as they happen
Other markets
✓The UK only
✓120+ other markets on the same basis
Price
✓Free
✓€1,420 a year
What neither can tell you. Dispensing in Wales, Scotland and Northern Ireland: the NHSBSA release is England only. What a pharmacy actually charged: we hold list prices. Prescriptions per clinic: visits measure reach, not scripts.
Also in Decide · beyond the UK
The UK sits in the same workspace as every other market, company, deal and trial we track.
125+countries

Benchmark UK momentum against Germany, Australia, Spain, Czechia, Poland and Switzerland, on the same basis.

1,050+company profiles

Financials, deals, trials, licences and news, joined up for every operator in the UK chain.

640+M&A and funding deals

Normalised to USD, source-linked, and tied to buyer, target and market. See the tracker.

2,300+clinical trials

Matched to the product and sponsor behind each. See the pipeline.

270+regulatory briefs

A living layer per market, tied to the country and the companies it affects.

Get the free report →
Explore Decide →

• Questions

What people ask us about the UK report.

Is the report free?
Yes. Leave your work email and we send the full 34-page PDF straight to your inbox.
Where does the data come from?
From the NHSBSA’s own dispensing records, obtained through two freedom-of-information releases (FOI_03941 and FOI-03965) covering private prescriptions for unlicensed cannabis-based medicines dispensed in England from January 2019 to February 2026. Import volumes come from Home Office FOIs, prices from dated formulary snapshots and clinic traffic from SimilarWeb estimates we compile every month.
Does it cover the whole UK?
No, and we say so on every page. The release covers England only, and dispensing submissions are manual, so some are missing — the record undershoots the UK market, probably by a wide margin. Treat every figure as a floor: adding 20–25% to any level is a conservative way to reach a total-UK view. Shares and trends are not affected.
Why count items rather than patients?
Because items are what the record actually contains. A prescription item is one product dispensed once — a 10 g jar or a single vape cartridge. Patient counts in the report come from Prohibition Partners and are attributed as such.
Why does the report stop at 2025?
January and February 2026 are still being filled in by late submissions, so reading them now would understate the market. The report reads 2026 through the formulary, list prices and imports instead, and the dispensing series updates in Decide as the records land.
What is the difference between the report and Decide?
The report is a snapshot, dated September 2026. Decide is where the same data keeps moving — every FOI release, formulary snapshot and clinic month as it arrives, alongside the same reconciled data for more than 120 other markets.

Inside Decide — the full picture

This page is the summary. Decide is the source.

Everything on this page is a rounded, point-in-time slice. The top-tier UK intelligence — and the ability to benchmark it against every other market — lives in Decide.
Included in Decide (paid)
🔓 In DecideFull NHSBSA SKU-level series — product, brand, format, potency, cultivar, importer — with monthly refresh and matching tables.
🔓 In DecideThe complete 2022–2025 volume stack plus full format / potency / cultivar breakdowns.
🔓 In DecideThe deeper prescriber and clinic concentration analysis.
🔓 In DecideCross-country comparators — Germany, Czechia, Poland, Switzerland and more — to benchmark UK momentum side by side.
🔓 In DecideThe M&A & funding tracker, earnings dashboard, clinical-trials pipeline, regulatory tracker and country/company profiles — one workspace.
Start now →
Just want the UK snapshot? Get the free datapack →

Everything on this page is live in Decide. Take it into your UK plan, with 120+ other markets beside it.

Start with the free report. When you need the numbers to keep moving, Decide is where they live.

Get the free report →
Explore Decide →